Related Experiment Videos
Immunologic abnormalities of juvenile arthritis
1Rheumatic Disease Service, Children's Hospital, Stanford University School of Medicine, Palo Alto, California 94304.
Clinical Orthopaedics and Related Research
|October 1, 1990
Summary
In children with chronic arthritis, few immunologic abnormalities are clinically useful. However, rheumatoid factor, antinuclear antibodies, and hypogammaglobulinemia can indicate specific conditions or risks.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Clinical Medicine
Background:
- Children with chronic arthritis exhibit numerous immunologic abnormalities.
- Most of these abnormalities lack clear clinical utility or understanding.
- Distinguishing specific immunologic markers is crucial for patient management.
Purpose of the Study:
- To review the clinical significance of immunologic abnormalities in pediatric chronic arthritis.
- To identify specific autoantibodies and immune markers relevant to diagnosis and prognosis.
Main Methods:
- Review of existing literature on immunologic findings in pediatric arthritis.
- Analysis of the clinical implications of rheumatoid factor, antinuclear antibodies, and hypogammaglobulinemia.
- Evaluation of other immune markers, cellular changes, and complement activation products.
Main Results:
- Rheumatoid factor presence suggests adult-type rheumatoid arthritis in children.
- Antinuclear antibodies increase the risk of developing uveitis.
- Hypogammaglobulinemia is linked to an increased susceptibility to infections.
Conclusions:
- While many immunologic abnormalities exist in pediatric arthritis, only a few, like rheumatoid factor and antinuclear antibodies, offer diagnostic or prognostic value.
- Currently, no single immunologic abnormality fully explains the pathogenesis of these diseases.
- Further research is needed to understand the role of immune system dysregulation in chronic childhood arthritis.